243 related articles for article (PubMed ID: 17878888)
1. Pregabalin (Lyrica) for fibromyalgia.
Med Lett Drugs Ther; 2007 Sep; 49(1270):77-8. PubMed ID: 17878888
[No Abstract] [Full Text] [Related]
2. Pregabalin for fibromyalgia: some relief but no cure.
Kim L; Lipton S; Deodhar A
Cleve Clin J Med; 2009 Apr; 76(4):255-61. PubMed ID: 19339642
[TBL] [Abstract][Full Text] [Related]
3. Pregabalin: a treatment for fibromyalgia and other painful conditions.
Smith SM
Nurs Womens Health; 2008 Oct; 12(5):432-5. PubMed ID: 18837723
[No Abstract] [Full Text] [Related]
4. Pregabalin: an alpha2-delta (alpha2-delta) ligand for the management of fibromyalgia.
Arnold L; Mease P; Silverman S
Am J Manag Care; 2010 May; 16(5 Suppl):S138-43. PubMed ID: 20586522
[TBL] [Abstract][Full Text] [Related]
5. A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.
Arnold LM; Russell IJ; Diri EW; Duan WR; Young JP; Sharma U; Martin SA; Barrett JA; Haig G
J Pain; 2008 Sep; 9(9):792-805. PubMed ID: 18524684
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of pharmacologic treatment of fibromyalgia in Mexico.
Arreola Ornelas H; Rosado Buzzo A; García L; Dorantes Aguilar J; Contreras Hernández I; Mould Quevedo JF
Reumatol Clin; 2012; 8(3):120-7. PubMed ID: 22386298
[TBL] [Abstract][Full Text] [Related]
7. Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia.
Sun P; Zhao Y; Zhao Z; Watson P
Curr Med Res Opin; 2011 Sep; 27(9):1793-801. PubMed ID: 21810060
[TBL] [Abstract][Full Text] [Related]
8. Pregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: an open-label, prospective trial.
Calandre EP; Morillas-Arques P; Rodriguez-Lopez CM; Rico-Villademoros F; Hidalgo J
Pharmacopsychiatry; 2007 Mar; 40(2):68-71. PubMed ID: 17447176
[TBL] [Abstract][Full Text] [Related]
9. Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia.
Zhao Y; Sun P; Watson P; Mitchell B; Swindle R
Pain Pract; 2011; 11(3):204-16. PubMed ID: 20807351
[TBL] [Abstract][Full Text] [Related]
10. Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia.
Arnold LM; Emir B; Murphy TK; Zeiher BG; Pauer L; Scott G; Petersel D
Clin Ther; 2012 May; 34(5):1092-102. PubMed ID: 22503162
[TBL] [Abstract][Full Text] [Related]
11. Treatment response to pregabalin in fibromyalgia pain: effect of patient baseline characteristics.
Emir B; Murphy TK; Petersel DL; Whalen E
Expert Opin Pharmacother; 2010 Oct; 11(14):2275-80. PubMed ID: 20812879
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.
Mease PJ; Russell IJ; Arnold LM; Florian H; Young JP; Martin SA; Sharma U
J Rheumatol; 2008 Mar; 35(3):502-14. PubMed ID: 18278830
[TBL] [Abstract][Full Text] [Related]
13. Delirium secondary to pregabalin.
Hickey C; Thomas B
Gen Hosp Psychiatry; 2012; 34(4):436.e1-2. PubMed ID: 22177026
[TBL] [Abstract][Full Text] [Related]
14. Impact of a prior authorization for pregabalin on health plan drug expenditures.
Bazalo G; Weiss RC; Joshi AV
Am J Manag Care; 2010 May; 16(5 Suppl):S154-9. PubMed ID: 20586524
[TBL] [Abstract][Full Text] [Related]
15. Potential drug-drug and drug-condition interactions among fibromyalgia patients initiating pregabalin or duloxetine: prevalence and health care expenditure impact.
Johnston SS; Udall M; Cappelleri JC; Johnson BH; Shrady G; Chu BC; Silverman SL
Pain Med; 2014 Aug; 15(8):1282-93. PubMed ID: 24401017
[TBL] [Abstract][Full Text] [Related]
16. Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports.
Straube S; Derry S; Moore RA; McQuay HJ
Rheumatology (Oxford); 2010 Apr; 49(4):706-15. PubMed ID: 20056767
[TBL] [Abstract][Full Text] [Related]
17. Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine.
Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
Pain Pract; 2012 Jan; 12(1):14-22. PubMed ID: 21615857
[TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective.
Lloyd A; Boomershine CS; Choy EH; Chandran A; Zlateva G
J Med Econ; 2012; 15(3):481-92. PubMed ID: 22339078
[TBL] [Abstract][Full Text] [Related]
19. Estimating the economic benefits of positive shifts in fibromyalgia severity: an exploratory analysis based on modeling of clinical trial data of pregabalin.
Cappelleri JC; Bushmakin AG; Zlateva G; Chandran A
J Med Econ; 2013; 16(1):55-61. PubMed ID: 22954060
[TBL] [Abstract][Full Text] [Related]
20. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial.
Crofford LJ; Rowbotham MC; Mease PJ; Russell IJ; Dworkin RH; Corbin AE; Young JP; LaMoreaux LK; Martin SA; Sharma U;
Arthritis Rheum; 2005 Apr; 52(4):1264-73. PubMed ID: 15818684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]